Journal
NATURE REVIEWS CANCER
Volume 1, Issue 2, Pages 118-129Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/35101072
Keywords
-
Categories
Ask authors/readers for more resources
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available